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Background: Many pathophysiologic alterations in patients with major burns can cause changes in the response of 
propofol. The aim of this study is to determine the appropriate induction dose of propofol using a slow infusion rate 
for major burn patients to obtain desirable sedation and hypnotic conditions with minimal hemodynamic changes.
Methods: 45 adults with major burns and who were electively scheduled for escharectomy less than a week after 
injury were recruited. For induction with propofol, the patients were randomly allocated to one of two groups (group 1: 
1.5 mg/kg, n = 20 and group 2: 2.0 mg/kg, n = 25). The infusion rate was 20 mg/kg/hr. The systolic and diastolic blood 
pressure (SBP, DBP), the heart rate, the bispectral index and the modified observers’ assessment of the alertness/
sedation scale (OAA/S) were measured before the induction and after the propofol infusion, as well as immediately, 
3 and 5 minutes after intubation.
Results: The SBP and DBP were significantly decreased after the propofol infusion in both group, but there were no 
significant differences between the two groups. The BIS values after the propofol infusion and intubation were 44.2 ± 
16.1 and 43.5 ± 13.8 in group 1, and 45.6 ± 10.3 and 46.5 ± 11.4 in group 2, respectively, and there were no differences 
between the 2 groups.
Conclusions: When propofol is administrated to major burn patients, an induction dose of 1.5 mg/kg is appropriate 
and a slow infusion rate of 20 mg/kg/hr is safe for maintaining the desired hypnotic conditions and this dose and rate 
cause no significant hemodynamic problems. (Korean J Anesthesiol 2011; 60: 161-166)
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Introduction
    Major burn patients experience pathophysiological changes 
due to the burns such as change in their metabolic function, 
blood flow and protein synthesis, and increased cardiac 
output. These affect the pharmokinetics of drugs such as drug 
distribution, biochemical changes and protein binding; and the 
clinical cases have shown that the pharmodynamic responses of 
major burn patients are different from those of healthy patients 
[1,2]. 
    Propofol has a short context-sensitive half-life and a short 
effect-site equilibration time. Used as a sedative and general 
anesthetic, its advantage lies in that it can be titrated [3]. But 
the arterial pressure decreases according to the anesthetic 
induction dose, and this is regardless of disorders of the 
cardiovascular system; propofol 2-2.5 mg/kg brings about a 
25-40% drop in blood pressure [4]. This occurs with a preload 
and afterload reduction without compensative responses such 
as a rise in the heart rate or cardiac output [5]. This can worsen 
due to factors such as a large dose and a fast infusion rate [6]. 
Studies on the induction doses, the anesthesia induction time 
and the hemodynamic changes to different propofol infusion 
rates have shown that the slower the infusion rate, the lower the 
required dose for anesthetics and the longer the time required 
for anesthesia induction, but the drop in blood pressure 
decreases [7].
    In burn patients, propofol is a commonly used drug for 
anesthesia induction and maintenance and for sedation in the 
ICU. However in major burn patients, the suggested dose for 
propofol’s intravenous administration, when used alone, is not 
known.
    In the presented study, the authors used the BIS, which is 
commonly used to measure the patients’ level of sedation 
and hypnosis, for major burn patients and the same dose of 
propofol as was given to healthy adult patients was infused at 
a slow infusion rate to determine what dose of propofal could 
maintain hemodynamic stability and adequate sedated and 
hypnotic states. 
Materials and Methods
    The present study received the approval from our hospital’s 
ethics committee. The authors visited the patients and 
explained the details of the study. The patients then gave their 
written consent to participate in this study.
    The patient-subjects were of the age range 18-60 years with 
burns that were 25% or more of the total body surface area 
(TBSA). They were successfully resuscitated, and they were in 
the acute phase within 1-week post-injury. They were ASA II and 
III patients scheduled for escharectomy. The patients were not 
given hypertensors prior to surgery in the ICU. The patients who 
were chosen were healthy enough to follow the requirements 
of the study. The patients were randomly placed in the propofol 
1.5 mg/kg group (Group 1, n = 20) or the propofol 2.0 mg/kg 
group (Group 2, n = 25). There were no significant differences 
between the patient groups for age, weight or height (Table 1). 
Patients were excluded from the study if they had a past history 
of disorders of the heart, liver, kidney and/or central nervous 
system, if they had taken sedatives or sleeping pills for a long 
period, and if they were pregnant or allergic to propofol. The 
patients with facial burns were excluded from the study because 
of their difficulty have BIS sensors attached.
    There was no premedication given because it has a sedative 
effect and an effect on the cardiovascular system. Upon arriving 
on the surgery table the patient was stabilized; afterwards the 
EKG, the noninvasive blood pressure monitor and the pulse-
oximeter were attached. To evaluate the depth of sedation, BIS 
monitor (A-3000 BIS monitor, Aspect Medical System, USA) 
sensors (BIS
TM Quatro, Aspect Medical system, Norwood, MA) 
were attached to the patient’s forehead and between the eyes 
and hairline. After confirming that the BIS values showed no 
interference, the wrist was anesthetized for A-line monitoring 
with local anesthetics. The radial artery was cannulated. At this 
point the blood pressure, heart rate and BIS values were taken 
for the baseline measurements. The BIS values were recorded 
after 15 seconds. 
    All the patients were given 100% oxygen at 10 L/min for 5 
minutes for preoxygenation. Normal saline 150-200 ml was 
intravenously administered through the central vein before 
anesthesia induction. Afterwards, a mask was placed on the 
patient to assist breathing. Using an infusion pump (Terufusion 
Syringe Pump TE-311, Japan) 1% propofol (Fresofol 1%, 
Fresenius Kabi, Austria) at 1.5 mg/kg was administered to the 
Group 1 patients and 2.0 mg/kg propofol was administered 
to Group 2 at 20 mg/kg/hr. When the dose was completely 
infused, the blood pressure, heart rate, OAA/S (modified 
observer’s assessment of alertness/sedation scale) and BIS 
value were recorded (Table 2). If the systolic pressure was 
Table 1. Patient Characteristics
Group 1 (n = 20) Group 2 (n = 25)
Age (yr)
Body weight (kg)
Height (cm)
Gender (M/F)
Total body surface area (%)
Elapsed time from burn (day)
43.1 ± 12.1
63.0 ± 10.5
166.5 ± 9.3
16/4
29.7 ± 4.6
5.6 ± 1.1
45.2 ± 12.4
65.4 ± 12.9
167.1 ± 7.2
17/8
30.2 ± 4.7
5.4 ± 1.2
Values are means ± SDs or the number of patients. There were no 
significant differences between the two groups. Group 1: propofol 1.5 
mg/kg, Group 2:  propofol 2.0 mg/kg.163 www.ekja.org
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reduced to below 75 mmHg or 40% or more of the baseline 
blood pressure, then ephedrine was used to adjust the blood 
pressure. After the drug was completely infused, rocuronium 
1.0 mg/kg was immediately intravenously administered. After 
adequate muscle relaxation, one third-year resident performed 
all the endotracheal intubations. The appropriate location of 
the endotracheal tube was confirmed by monitoring the end-
tidal CO2 (ETCO2) and by auscultation. Mechanical ventilation 
was performed with fresh O2 at 3 L/min. The PETCO2 was 
maintained at around 32-34 mmHg. Immediately after 
endotracheal intubation, propofol was continuously infused 
at 100 μg/kg/min. The blood pressure, heart rate and BIS value 
were recorded immediately, 3 min and 5 min after extubation. 
The day after surgery, the patient was visited to check if he or 
she recalled the beginning point of anesthesia.
    The results are expressed as means ± standard deviation. The 
statistical analysis was performed using SPSS (version 13.0, 
SPSS, USA). Independent sample t-tests were performed to 
compare the two groups. Within each group, each point was 
analyzed using repeated measures of ANOVA. A P value less 0.05 
was considered statistically significant. 
Results
    The severity of the burn based on the Classic Lund and 
Browder chart in the two groups was on average about 30% 
TBSA. The time that elapsed since the injury was 5 days (Table 1). 
Compared to the baseline value, the systolic pressure after the 
propofol was intravenously administered decreased by 11.5% 
in Group 1 and 16.3% in Group 2. This decrease was significant 
in both groups. Immediately after endotracheal intubation, the 
systolic pressure significantly rose by 24.9% in Group 1 and by 
22% in Group 2 (P < 0.05). However, there were no significant 
differences between the two groups for the blood pressure 
changes (Fig. 1). The diastolic pressure showed the same 
pattern as the systolic pressure (Fig. 2). Ephedrine was not used 
for any patients in both groups for controlling blood pressure. 
There were no differences of the heart rates that were measured 
at the specified periods between the groups. But the heart rate 
in the two groups immediately after intubation was significantly 
increased compared to the baseline values (P < 0.05) (Fig. 3). 
    The BIS values immediately before intubation in Group 1 
and Group 2 were 44.2 ± 16.1 and 43.5 ± 13.8, respectively. 
Immediately after intubation, they were 45.6 ± 10.3 and 46.5 
± 11.4, respectively, and there was no significant difference 
between the two groups. At all times except for when the drugs 
were infused, the appropriate BIS range for general anesthesia 
was maintained (Fig. 4). 
Fig. 1. Changes of the systolic blood pressure (SBP). There were no 
significant differences between the two groups. Preintubation: after 
propofol infusion, Intubation: immediately after intubation, 1, 2, 3 
and 5 min: 1, 2, 3 and 5 minutes after intubation. Group 1: propofol 
1.5 mg/kg, Group 2: propofol 2.0 mg/kg.
Fig. 2. Changes of the diastolic blood pressure (DBP). There were no 
significant differences between the two groups. Preintubation: after 
propofol infusion, Intubation: immediately after intubation, 1, 2, 3 
and 5 min: 1, 2, 3 and 5 minutes after intubation. Group 1: propofol 
1.5 mg/kg, Group 2: propofol 2.0 mg/kg.
Table 2. Responsiveness Scores of the Modified Observer’s 
Assessment of Alertness/Sedation Scale
Response Score level
Responds readily to their name spoken in a normal tone
Lethargic response to their name spoken in a normal
  tone
Response only after their name is called loudly and/or
  repeatedly
Response only after name spoken with mild prodding 
  or shaking
Does not respond to mild prodding or shaking
Does not respond to noxious stimuli (Trapezius   squeezing)
5 (Alert)
4
3
2
1
0164 www.ekja.org
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    The OAA/S scores after propofol infusion were 95% in Group 
1 and they were between 96% and 1 in Group 2. None of the 
patients in either of the two groups had any recall of the surgery.
Discussion
    Different patients have various responses to the use of 
propofol. So the dose should be titrated according to the 
situation and according to the patient’s condition. The factors 
affecting the decision for the dose of propofol dose are gender, 
age, weight, the patient’s condition, the type of surgery and the 
drugs that are used in combination with propofol [4].
    Major burn patients with great tissue damage experience 
ischemia-reperfusion injury and excessive fluid resuscitation 
from burn shock, which cause secondary complications and 
systemic inflammation [8]. Hypovolemia, a reduction of the 
cardiac output, increased pulmonary vascular resistance and 
erythropyknosis also occur. If resuscitation is successful 24-
48 hours post-injury, then a hypermetabolic state follows. 
This is characterized by an increase in oxygen consumption, 
CO2 production and the cardiac output, and tachycardia 
occurs too. This state may continue for 24 months until the 
burns completely heal [9]. Generally after the resuscitation 
from all types of trauma and including burns, the functional 
extracellular and intracellular volumes increase [10]. The great 
quantity of fluid that must be administered for the purpose 
of resuscitation usually worsens the increased capillary 
permeability and interstitial edema. Burns make body fluid 
loss in the area of the wound inevitable [11]. At this point the 
intravascular volume relatively decreases, which may cause the 
patient to have a reaction to the drugs that change intravascular 
resistance. So when handling patients with major burns, one 
must be aware of such severe hemodynamic changes and be 
cautious and aware of the distribution of the generally used 
anesthetics and the changes in response to them. 
    One study on the effects of burns on the pharmokinetics of 
propofol in pediatric patients with minor burns showed that 
the required dose of propofol was increased [12]. In a patient 
who is in a hypermetabolic state from major burns, there is an 
increase in the clearance rate of propofol and an increase in 
the volume of distribution, so there is an opinion that the initial 
dose or maintenance dose needs to be increased [13]. However 
in the present study, on deciding the total dose of propofol for 
the major burn patients, we took into consideration the relative 
hypovolemia and hemodynamic variability that can be caused 
by the drugs. We first started at a range similar to what would 
be used in generally healthy patients and then we moved to 1.5 
mg/kg and 2.0 mg/kg. The patients were administered propofol 
at a slow infusion rate of 20 mg/kg/hr. The sedated states, 
hypnotic states and hemodynamic changes were monitored. 
The two groups did not have significant differences of their 
systolic pressure, diastolic pressure or heart rate. Propofol 
1.5 mg/kg and 2.0 mg/kg were infused with the patients in a 
sedated and hypnotic state, which were appropriate doses for 
the two groups. So it appears that a slow infusion of propofol 
beyond 1.5 mg/kg is unnecessary even in burn patients. In 
fact, for the dose of 1.5 mg/kg, the BIS values of the patients 
were adequately decreased, and after propofol infusion, the 
inhibitory effect on the cardiovascular system was not great. 
Considering that the patients mostly showed tachycardia, this 
Fig. 3. Changes of heart rate (HR). There were no significant 
differences between the two groups. Preintubation: after propofol 
infusion, Intubation: immediately after intubation, 1, 2, 3 and 5 min: 
1, 2, 3 and 5 minutes after intubation. Group 1: propofol 1.5 mg/kg, 
Group 2: propofol 2.0 mg/kg.
Fig. 4. Changes of the bispectral index (BIS) values. Preintubation: 
immediately before intubation, Intubation: after propofol infusion, 
1, 2, 3 and 5 min: 1, 2, 3 and 5 minutes after intubation. Group 1: 
propofol 1.5 mg/kg, Group 2: propofol 2.0 mg/kg.165 www.ekja.org
Korean J Anesthesiol Bae, et al.
is believed to be due to their probable hypermetabolic state 
with an increased cardiac output, their pre-administration of 
crystalloid solution of 150-200 ml and the slow infusion of 20 
mg/kg/hr of propofol.
    The dose of propofol for the induction of anesthesia for a 
healthy adult is 1-2.5 mg/kg. The suggested infusion rate 
for propofol is 100-200 μg/kg/min. For fast induction of 
anesthesia, the infusion rate is 80 mg/kg/hr [4]. In the present 
study the anesthesia doses were set as 1.5 mg/kg and 2.0 mg/kg. 
After the doses were completely infused, the infusion rate was 
set at a slow rate of 20 mg/kg/hr. The infusion rate for anesthesia 
maintenance was set at 100 μg/kg/min. In all the phases, the BIS 
value was below 65. So, these were confirmed as the suitable 
total dose and maintenance rates for maintaining anesthesia in 
major burn patients without complications.
    Generally, the responses to oral command are checked during 
the evaluation of loss of consciousness. In the present study, as 
an assessment tool for sedation, a modified OAA/S score and 
the BIS, which are commonly used to check the state of sedation 
and hypnosis, were used in order to compare the differences 
between the two groups. The correlation between the OAA/
S score and the BIS and the correlation between the effect-site 
concentration of BIS and propofol were reported to be very 
positive [14,15]. BIS values of 40-65 are the suggested range for 
a patient under general anesthesia; 65-85 is for a sedated state, 
but alertness is possible [16]. A BIS value of 65 or above and 
2 on the OAA/S score is not adequate for achieving hypnosis 
for endotracheal intubation. In both groups of the present 
study, after the intravenous infusion of drugs and immediately 
after endotracheal intubation, the BIS value was 65 or below, 
which was appropriate for general anesthesia. In the present 
study 1 patient in Group 1 (5%) and 1 patient (4%) in Group 2 
showed an OAA/S of 2. But both patients showed a BIS value 
of 65 or below. There was positive correlation between the BIS 
and OAA/S. Yet it is hard to remove the observer’s bias. So for 
inducing anesthesia, the BIS is considered the more appropriate 
method for evaluating the appropriate state of hypnosis.
    It is known that the slower the infusion rate of propofol, the 
smaller are the hemodynamic changes, a lesser quantity of 
propofol is required for anesthesia and the anesthesia time is 
longer [7,17]. In the present study the slow infusion rate resulted 
in the reduction of the systolic pressure by 11.5% and 16.3% in 
the groups, which is 25-40% lower than the usual reduction 
rate, confirming that slow infusion is a safe method. 
    However, this is the first limitation of our study. The induction 
time was long: it was a mean of 4.5 min in Group 1 and 6 min 
in Group 2. In both groups, the lowest systolic pressure was at 
the time point after propofol infusion, but immediately before 
endotracheal intubation. There was no case of hypotension that 
required drug treatment. Further studies with faster infusion 
should be conducted in order to achieve safer and faster 
anesthesia induction. The second drawback of the present 
study was that there was no management for the elevation of 
the blood pressure and heart rate due to the irritation from 
the endotracheal tube. Using opioids is beneficial for the ideal 
circumstance for endotracheal intubation [18]. But opioid can 
affect the BIS, so the combined use of drugs that do not affect 
the BIS values but that can still prevent elevation of the systolic 
pressure and heart rate, such as esmolol, should be considered 
[19]. In this study, there were no differences in the changes 
of the systolic pressure between the two groups. So rather 
than raising the dose of propofol to increase the difference in 
hemodynamic changes, the use of hypotensors is considered 
more appropriate. The third drawback was that patients with 
burns of more than 40% of the TBSA and this is accompanied 
with burns on the face, head and neck area were not included 
in this study. Major burns are defined as more than 25% of the 
TBSA. Patients with more severe burns are expected to have 
greater hemodynamic changes. So if such patients as mentioned 
above had been included, the study would have been more 
comprehensive. It is difficult to attach sensors on patients with 
face, head and neck burn, as the attachment may cause skin 
damage. BIS values cannot be taken for these patients. So we 
think that an alternative method to directly attach sensors to the 
skin needs to be found.
    In conclusion, for continuous infusion for the prevention 
of hypotension, a 1.5 mg/kg dose slowly infused at the rate 20 
mg/kg/hr will not cause a significant decrease in the blood 
pressure and it will maintain an adequate hypnotic state for 
general anesthesia even in major burn patients. Moreover, a 
slow infusion of propofol is safe for reducing the induction time. 
However, further studies that will focus on rates of infusion are 
needed.
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